Verrica Pharmaceuticals I... (VRCA)

NASDAQ: VRCA · Real-Time Price · USD

0.46

-0.01 (-2.19%)

At close: May 02, 2025, 3:59 PM

0.46

-0.15%

After-hours: May 02, 2025, 04:09 PM EDT

Verrica Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-76.58M	-67M	-24.49M	-35.08M	-42.69M	-28.21M	-20.65M	-4.46M	-1.91M
Depreciation & Amortization	1.27M	836K	718K	472K	229K	257K	20K	n/a	n/a
Stock-Based Compensation	7.16M	14.38M	4.99M	6.05M	9.82M	3.33M	2.25M	82K	9K
Other Working Capital	-1.74M	11.59M	-1.46M	-1.03M	2.47M	-1.95M	145K	-270K	222K
Other Non-Cash Items	5.19M	3.35M	1.93M	1.44M	940K	-1.06M	-435K	18K	-62K
Deferred Income Tax	n/a	n/a	n/a	66K	-138K	n/a	n/a	n/a	n/a
Change in Working Capital	2.03M	9.86M	-1.8M	-535K	1.64M	-1.73M	938K	-206K	293K
Operating Cash Flow	-60.93M	-38.58M	-18.65M	-27.58M	-30.21M	-27.41M	-17.87M	-4.58M	-1.61M
Capital Expenditures	-27K	-362K	-302K	-883K	-1.47M	-682K	-774K	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	-4.49M	-68.91M	-71.74M	-89.85M	-79.12M	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	59.01M	69M	69.85M	117.72M	n/a	n/a	n/a
Other Investing Acitivies	8K	n/a	-180K	-201K	-221K	-1.22M	-499K	n/a	n/a
Investing Cash Flow	-19K	-362K	54.04M	-998K	-3.58M	25.95M	-79.89M	n/a	n/a
Debt Repayment	-2.06M	44.08M	-43.75M	4.97M	34.46M	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	155K	-169K	-17K	558K	772K	423K	n/a	-281K	-17K
Financial Cash Flow	37.73M	74.21M	-16.87M	33.65M	35.23M	423K	99.38M	12.72M	483K
Net Cash Flow	-23.22M	35.27M	18.52M	5.07M	1.45M	-1.03M	1.61M	8.14M	-1.13M
Free Cash Flow	-60.95M	-38.94M	-18.95M	-28.46M	-31.68M	-28.09M	-18.65M	-4.58M	-1.61M